logo

Intec Pharma Ltd. (NTEC)



Trade NTEC now with
  Date
  Headline
2/27/2019 7:17:08 AM Intec Pharma Q4 Net Loss $12.6 Mln Vs. Net Loss $10.2 Mln Last Year
2/19/2019 7:09:26 AM Intec : AP-CD/LD Met Primary Endpoint Of Reducing Plasma Levodopa Variability Vs. Standard Oral CD/LD With Significance
1/2/2019 7:07:49 AM Intec Pharma Doses First Patient In Phase 1 Pharmacokinetic Study Of AP-THC
12/19/2018 9:30:19 AM  Intec Pharma Reviews 2018 Progress And Provides Outlook For 2019
11/9/2018 7:08:25 AM Intec Pharma 9-month Loss Per Share $1.01 Vs Loss $1.27 Last Year
10/22/2018 7:11:51 AM Intec Pharma Completes Enrollment Of Pivotal Phase 3 Clinical Trial Of Accordion Pill Carbidopa/Levodopa
8/15/2018 7:34:20 AM  Intec Pharma HY Loss/shr $0.75 Vs Loss $0.88 Prior Year
6/29/2018 7:02:57 AM Intec Pharma Appoints William Bradley Hayes To Board
5/15/2018 7:11:24 AM Intec Pharma Q1 Oss Per Share Attributed To Common Stockholders $0.40 Vs Loss $0.41 Last Year
4/24/2018 7:15:12 AM Intec Pharma Presented Phase 1 PK And Safety Data From Accordion Pill Carbidopa/Levodopa At AAN Annual Meeting
4/13/2018 4:02:48 PM Intec Pharma Announces Closing Of $35.4 Mln Public Offering Of Ordinary Shares
4/11/2018 9:05:27 AM Intec Pharma Prices Public Offering Of 6.75 Mln Ordinary Shares At $5.25/Shr
4/10/2018 4:13:26 PM Intec Pharma Announces Proposed Public Offering Of Ordinary Shares
3/26/2018 7:02:34 AM Intec Pharma Appoints Roger Pomerantz To Board Of Directors